Peritoneal carcinomatosis index and overall survival in patients taken to cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy.
| Autor: | López-Basave HN; Departamento de Gastroenterología., Morales-Vázquez F; Departamento de Ginecología Oncológica., Herrera-Gómez Á; Subdirección de Cirugía. Instituto Nacional de Cancerología, Ciudad de México, México., Miranda-Devora G; Departamento de Gastroenterología., Padilla-Rosciano AE; Departamento de Gastroenterología., Castillo-Morales C; Departamento de Gastroenterología., Paleta-Torres CA; Departamento de Gastroenterología., Vázquez-Cortes E; Departamento de Gastroenterología. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cirugia y cirujanos [Cir Cir] 2023; Vol. 91 (2), pp. 195-199. |
| DOI: | 10.24875/CIRU.22000272 |
| Abstrakt: | Background: The peritoneal carcinomatosis (PC) secondary to gastrointestinal or gynecological cancer has increased its incidence. It has a worse prognosis compared to other sites of metastasis. The peritoneal carcinomatosis index (PCI) establishes overall survival in patients with gastrointestinal or gynecological tumors and carcinomatosis. Objective: To evaluate the relationship of PCI to overall survival (OS) and recurrence-free survival (RFS) in patients treated with cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC). Method: A descriptive, retrolective study of 80 charts of patients with CP was conducted. We included patients with colon, ovarian, appendicular, pseudomyxoma and gastric tumors with CP treated with CRS plus HIPEC. The OS and RFS were determined according to the type of adenocarcinoma and the degree of differentiation. The OS and RFS were determined in months in patients with PCI > 15 PCI as well as in patients with PCI < 15 considering the tumor of origin. Results: Patients with ovarian tumors and pseudomyxoma with PCI < 15 presented OS > 70 months, compared to patients with gastric tumors (4 months). Conclusions: The PCI and histology are predictors of OS. Patients with ovarian tumors and PCI < 15 have higher OS, similar to pseudomyxomas. RFS was also higher in patients with PCI < 15. (Copyright: © 2023 Permanyer.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|